Boronicacid, B-[3-[(cyclopropylamino)sulfonyl]phenyl]-

• CAS: 913835-28-6
• Catalog Number: ACM913835286
• Category: Other Products
• Molecular Weight: 241.0738
• Molecular Formula: C9H12BNO4S
• Synonyms: 913835-28-6, N-Cyclopropyl 3-boronobenzenesulfonamide, (3-(N-Cyclopropylsulfamoyl)phenyl)boronic acid, N-cyclopropyl-3-boronobenzenesulfonamide, Boronicacid, B-[3-[(cyclopropylamino)sulfonyl]phenyl]-, ACMC-209r8z, SureCN520306, AGN-PC-07137H, CTK3I6391, MolPort-001-768-237, ANW-39585, OR3228, AKOS015833705, AG-H-74899, 3-(cyclopropylsulfamoyl)phenylboronic acid, AK-92334, BD221146, BP-13383, KB-58033, 3-(N-Cyclopropylsulphamoyl)benzeneboronic acid
• IUPAC Name: [3-(cyclopropylsulfamoyl)phenyl]boronic acid
• Canonical SMILES: B(C1=CC(=CC=C1)S(=O)(=O)NC2CC2)(O)O
• InChI Key: WIZSPBQIRRAOMO-UHFFFAOYSA-N
• Boiling Point: 484.4ºC at 760 mmHg
• Melting Point: 126-128ºC
• Flash Point: 246.8ºC
• Density: 1.45g/cm³
• Exact Mass: 241.05800
• Hazard Statements: Xi
• H-Bond Acceptor: 5
• H-Bond Donor: 3

Synthetic Use

Downstream Synthesis Route 1

• 875639-69-3
• 913835-28-6

• 1188409-83-7

Reference: [1]Current Patent Assignee: Novartis (w/o Sandoz); NOVARTIS AG - US2009/239847, 2009, A1
Location in patent: Page/Page column 45

Downstream Synthesis Route 2

• 913835-28-6
• 1580454-37-0

• 1580453-54-8

Reference: [1]Le Manach, Claire; Gonzàlez Cabrera, Diego; Douelle, Frederic; Nchinda, Aloysius T.; Younis, Yassir; Taylor, Dale; Wiesner, Lubbe; White, Karen L.; Ryan, Eileen; March, Corinne; Duffy, Sandra; Avery, Vicky M.; Waterson, David; Witty, Michael J.; Wittlin, Sergio; Charman, Susan A.; Street, Leslie J.; Chibale, Kelly
[Journal of Medicinal Chemistry, 2014, vol. 57, # 6, p. 2789 - 2798]

* For details of the synthesis route, please refer to the original source to ensure accuracy.